1. Home
  2. TVRD vs TTSH Comparison

TVRD vs TTSH Comparison

Compare TVRD & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • TTSH
  • Stock Information
  • Founded
  • TVRD 2017
  • TTSH 1985
  • Country
  • TVRD United States
  • TTSH United States
  • Employees
  • TVRD N/A
  • TTSH N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • TVRD Health Care
  • TTSH Finance
  • Exchange
  • TVRD Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • TVRD 246.5M
  • TTSH 264.5M
  • IPO Year
  • TVRD N/A
  • TTSH N/A
  • Fundamental
  • Price
  • TVRD $33.88
  • TTSH $6.11
  • Analyst Decision
  • TVRD Strong Buy
  • TTSH
  • Analyst Count
  • TVRD 5
  • TTSH 0
  • Target Price
  • TVRD $59.20
  • TTSH N/A
  • AVG Volume (30 Days)
  • TVRD 22.1K
  • TTSH 45.3K
  • Earning Date
  • TVRD 08-14-2025
  • TTSH 11-06-2025
  • Dividend Yield
  • TVRD N/A
  • TTSH N/A
  • EPS Growth
  • TVRD N/A
  • TTSH N/A
  • EPS
  • TVRD N/A
  • TTSH N/A
  • Revenue
  • TVRD N/A
  • TTSH $340,228,000.00
  • Revenue This Year
  • TVRD N/A
  • TTSH N/A
  • Revenue Next Year
  • TVRD N/A
  • TTSH N/A
  • P/E Ratio
  • TVRD N/A
  • TTSH N/A
  • Revenue Growth
  • TVRD N/A
  • TTSH N/A
  • 52 Week Low
  • TVRD $8.13
  • TTSH $4.62
  • 52 Week High
  • TVRD $36.71
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • TVRD 66.16
  • TTSH 47.11
  • Support Level
  • TVRD $29.33
  • TTSH $5.95
  • Resistance Level
  • TVRD $31.88
  • TTSH $6.35
  • Average True Range (ATR)
  • TVRD 2.09
  • TTSH 0.31
  • MACD
  • TVRD 0.49
  • TTSH 0.00
  • Stochastic Oscillator
  • TVRD 69.21
  • TTSH 28.04

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: